Relmada Therapeutics

-$0.41 (-1.34%) As of 3:10 PM UTC today

Why Robinhood?

You can buy or sell RLMD and other stocks, options, and ETFs commission-free!

About RLMD

Relmada Therapeutics, Inc. Common Stock, also called Relmada Therapeutics, is a clinical-stage biotechnology company.

CEO
Sergio Traversa
Employees
14
Headquarters
New York, New York
Founded
2012

RLMD Key Statistics

Market Cap
512.87M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
103.45K
High Today
$31.62
Low Today
$29.97
Open Price
$30.99
Volume
11.52K
52 Week High
$54.00
52 Week Low
$28.40

RLMD Earnings

-$1.39
-$0.93
-$0.46
$0.00
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Aug 11, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure